BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36811845)

  • 1. Endometrioid Adenocarcinoma Resembling Cutaneous Pilomatrix Carcinoma: A Case Report of an Aggressive Neoplasm in a Young Woman With Diffusely Aberrant Beta-catenin Expression and Associated Morular Metaplasia and Atypical Polypoid Adenomyoma-type Change.
    Keane E; Floyd R; McDonnell C; Beirne JP; Ó'Riain C; Komanyane L
    Int J Gynecol Pathol; 2023 Sep; 42(5):466-471. PubMed ID: 36811845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FIGO Grade 3 Endometrioid Adenocarcinomas With Diffusely Aberrant β-Catenin Expression: An Aggressive Subset Resembling Cutaneous Pilomatrix Carcinomas.
    Weisman P; Park KJ; Xu J
    Int J Gynecol Pathol; 2022 Mar; 41(2):126-131. PubMed ID: 33811207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of SATB2 and p16 reactivity aid in the distinction of atypical polypoid adenomyoma from myoinvasive endometrioid carcinoma and benign adenomyomatous polyp on endometrial sampling.
    Worrell HI; Sciallis AP; Skala SL
    Histopathology; 2021 Jul; 79(1):96-105. PubMed ID: 33459390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometrial Endometrioid Carcinoma With Ovarian Metastasis Showing Morula-like Features in a Patient With Cowden Syndrome: A Case Report.
    Kuno I; Tate K; Yoshida H; Takahashi K; Kato T
    Int J Gynecol Pathol; 2020 Jan; 39(1):36-42. PubMed ID: 30676432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stromal p16 Expression Helps Distinguish Atypical Polypoid Adenomyoma From Myoinvasive Endometrioid Carcinoma of the Uterus.
    Kihara A; Amano Y; Yoshimoto T; Matsubara D; Fukushima N; Fujiwara H; Niki T
    Am J Surg Pathol; 2019 Nov; 43(11):1526-1535. PubMed ID: 31600177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent β-catenin gene mutations in atypical polypoid adenomyoma of the uterus.
    Takahashi H; Yoshida T; Matsumoto T; Kameda Y; Takano Y; Tazo Y; Inoue H; Saegusa M
    Hum Pathol; 2014 Jan; 45(1):33-40. PubMed ID: 24182564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunophenotype of Atypical Polypoid Adenomyoma of the Uterus: Diagnostic Value and Insight on Pathogenesis.
    Travaglino A; Raffone A; Saccone G; Fuggi M; De Placido G; Mascolo M; Mollo A; Insabato L; Zullo F
    Appl Immunohistochem Mol Morphol; 2020 Sep; 28(8):646-653. PubMed ID: 31855579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD10 immunostaining distinguishes atypical polypoid adenomyofibroma (atypical polypoid adenomyoma) from endometrial carcinoma invading the myometrium.
    Ohishi Y; Kaku T; Kobayashi H; Aishima S; Umekita Y; Wake N; Tsuneyoshi M
    Hum Pathol; 2008 Oct; 39(10):1446-53. PubMed ID: 18619643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTNNB1 Mutations and Aberrant β-Catenin Expression in Ovarian Endometrioid Carcinoma: Correlation With Patient Outcome.
    Zyla RE; Olkhov-Mitsel E; Amemiya Y; Bassiouny D; Seth A; Djordjevic B; Nofech-Mozes S; Parra-Herran C
    Am J Surg Pathol; 2021 Jan; 45(1):68-76. PubMed ID: 32769429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case of atypical polypoid adenomyoma that possibly underwent a serial progression from endometrial hyperplasia to carcinoma.
    Fukuda M; Sakurai N; Yamamoto Y; Taoka H; Asakawa Y; Kurasaki A; Oharaseki T; Takahashi K; Kubushiro K
    J Obstet Gynaecol Res; 2011 May; 37(5):468-71. PubMed ID: 21272150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical polypoid adenomyoma of the endometrium: diagnosis and treatment. A case report.
    Domeniconi L; Amadori A; Maniglio P; Saragoni L
    Pathologica; 2020 Dec; 112(4):214-218. PubMed ID: 33393525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of endometrial carcinoma arising in a 36-year-old woman with uterine atypical polypoid adenomyoma (APA).
    Bakalianou K; Salakos N; Iavazzo C; Paltoglou G; Papadias K; Kondi-Pafiti A
    Eur J Gynaecol Oncol; 2008; 29(3):298-9. PubMed ID: 18592801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coexistence of endometrioid adenocarcinoma in atypical polypoid adenomyoma.
    Sonoyama A; Kanda M; Ojima Y; Kizaki T; Ohara N
    Kobe J Med Sci; 2014 Dec; 60(3):E74-7. PubMed ID: 25612673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesonephric-like adenocarcinoma of the ovary with squamoid morular metaplasia, aberrant β-catenin expression, and concurrent FGFR2 and CTNNB1 mutations: a case report.
    Xu J; Park KJ; Rehrauer WM; Weisman PS
    Virchows Arch; 2024 Jan; 484(1):147-150. PubMed ID: 36856760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CTNNB1 p.D32A (c.95A > C) somatic mutation in stage I grade 1 endometrioid endometrial carcinoma with lung metastasis: a case report.
    Zhong L; Jiang W; RutieYin ; Liu H; Song L
    BMC Med Genomics; 2023 Jun; 16(1):137. PubMed ID: 37328769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corded and Hyalinized Endometrioid Adenocarcinoma (CHEC) of the Uterine Corpus are Characterized by CTNNB1 Mutations and Can Show Adverse Clinical Outcomes.
    Ladwig NR; Umetsu SE; Zaloudek C; Rabban J; Garg K
    Int J Gynecol Pathol; 2021 Mar; 40(2):103-115. PubMed ID: 32909971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CTNNB1 -mutated High-grade Endometrioid Carcinoma With Extensive Squamous and Shadow Cell Differentiation Can Mimic Pilomatrix Carcinoma.
    Mendoza R; Kertowidjojo E
    Int J Gynecol Pathol; 2023 May; 42(3):325-326. PubMed ID: 35639408
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinicopathological features and prognostic significance of CTNNB1 mutation in low-grade, early-stage endometrial endometrioid carcinoma.
    Ruz-Caracuel I; López-Janeiro Á; Heredia-Soto V; Ramón-Patino JL; Yébenes L; Berjón A; Hernández A; Gallego A; Ruiz P; Redondo A; Peláez-García A; Mendiola M; Hardisson D
    Virchows Arch; 2021 Dec; 479(6):1167-1176. PubMed ID: 34420090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. beta-Catenin expression pattern, beta-catenin gene mutations, and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas.
    Moreno-Bueno G; Gamallo C; Pérez-Gallego L; de Mora JC; Suárez A; Palacios J
    Diagn Mol Pathol; 2001 Jun; 10(2):116-22. PubMed ID: 11385321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CTNNB1 (beta-catenin) mutation identifies low grade, early stage endometrial cancer patients at increased risk of recurrence.
    Kurnit KC; Kim GN; Fellman BM; Urbauer DL; Mills GB; Zhang W; Broaddus RR
    Mod Pathol; 2017 Jul; 30(7):1032-1041. PubMed ID: 28281553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.